“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart
Article: A-147 DIAGNOSTIC PERFORMANCE EVALUATION OF QUANTIA D-DIMER® REAGENT FOR PULMONARY EMBOLISM IN CLINICAL PRACTICE
A-147 DIAGNOSTIC PERFORMANCE EVALUATION OF QUANTIA D-DIMER® REAGENT FOR PULMONARY EMBOLISM IN CLINICAL PRACTICE
Reviews
There are no reviews yet.
Be the first to review “Article: A-147 DIAGNOSTIC PERFORMANCE EVALUATION OF QUANTIA D-DIMER® REAGENT FOR PULMONARY EMBOLISM IN CLINICAL PRACTICE” Cancel reply
Reviews
There are no reviews yet.